Rodrigo Machado-Vieira1,2
, João Quevedo2,3,4,5
, Lokesh Shahani2
, Jair C. Soares1,2,4
DOI: 10.1590/1516-4446-2020-0024
Epub: January 7 2021
1Experimental Therapeutics and Molecular Pathophysiology Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
2Center of Excellence in Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth, Houston, TX, USA
3Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth, Houston, TX, USA
4Neuroscience Graduate Program, The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA
5Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
Rodrigo Machado-Vieira, The University of Texas Health Science Center at Houston (UTHealth), McGovern Medical School, Faillace Department of Psychiatry and Behavioral Sciences, 1941 East Road, Houston, TX 77054, USA. E-mail: Rodrigo.MachadoVieira@uth.tmc.edu